Shares of Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $8.68 and traded as low as $7.25. Mannatech shares last traded at $7.4150, with a volume of 1,627 shares trading hands.
Analyst Ratings Changes
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Mannatech in a report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on Mannatech
Mannatech Trading Up 0.3%
Mannatech (NASDAQ:MTEX – Get Free Report) last announced its earnings results on Wednesday, November 12th. The company reported $1.01 earnings per share for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%. The firm had revenue of $29.16 million for the quarter.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Stories
- Five stocks we like better than Mannatech
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- They just tried to kill gold
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
